Evidence map›Paper›PMID 35637916›Full record

ArticleRespiratory medicine case reports2022

Combination of acute exacerbation of idiopathic nonspecific interstitial pneumonia and pulmonary embolism after booster anti-COVID-19 vaccination.

Marialuisa Bocchino, Gaetano Rea, Anna Buonocore, Roberta Lieto, Annalisa Mazzocca, Arcangela Di Domenico, Anna A Stanziola

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Vaccinations in patients with interstitial lung diseases: a narrative review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Marialuisa BocchinoRespiratory Medicine Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy.
Gaetano ReaDepartment of Radiology, Monaldi Hospital, AO dei Colli, Naples, Italy.
Anna BuonocoreRespiratory Medicine Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy.
Roberta LietoDepartment of Radiology, Monaldi Hospital, AO dei Colli, Naples, Italy.
Annalisa MazzoccaRespiratory Medicine Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy.
Arcangela Di DomenicoRespiratory Medicine Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy.
Anna A StanziolaRespiratory Medicine Unit, Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy.
Ospedale Monaldi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease-2019 (COVID-19) is a systemic disorder with the lung and the vasculature being the preferred targets. Patients with interstitial lung diseases represent a category at high risk of progression in the case of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection, and as such deserve special attention. We first describe the combination of acute exacerbation and pulmonary embolism in an elderly ILD patient after booster anti-COVID-19 mRNA vaccination. Vaccines availability had significantly and safety impacted COVID-19 morbidity and mortality worldwide. Immunization against COVID-19 is indisputable but must not be separated from the awareness of potential adverse effects in

Indexed as

Acute exacerbationAE, acute exacerbationCOVID-19, Coronavirus disease 2019GGO, ground glass opacityHRCT, high-resolution computed tomographyILD, interstitial lung diseaseiNSIP, idiopathic nonspecific interstitial pneumoniaInterstitial lung diseaseIPF, idiopathic pulmonary fibrosisMIP, maximum intensity projectionPulmonary embolismSARS-CoV-2 anti-COVID-19 mRNA vaccinationSARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus-2

Identifiers

PMID35637916
PMCPMC9126827
OpenAlexW4285300734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.